Clinical Trials on HRD Cancer
Total 51580 results
-
Zhejiang Cancer HospitalJiangsu Hengrui Pharmaceutical Co., Ltd.Not yet recruitingFemale Breast Cancer Patients | Histopathologically Confirmed Advanced HR +/HER2-invasive Breast Cancer | HRD Positive Advanced Breast Cancer
-
Hubei Biological Medicine Industrial Technology...UnknownAdvanced Solid Tumors | HRD | BRCA MutationChina
-
Tianjin Medical University Cancer Institute and...RecruitingAdvanced HER2 Negative Breast Carcinoma | HRD+Breast CancerChina
-
wang shusenRecruitingAdvanced HER2 Negative Breast Carcinoma HRD+Breast CancerChina
-
Walid Shaib, MDGlaxoSmithKline; Emory UniversityWithdrawnMetastatic Cancer | Cholangiocarcinoma | HRD
-
AZ-VUBAstraZeneca; Kom Op Tegen KankerRecruitingAdvanced Cancers Harbouring Mutations in HRGBelgium
-
University of MalayaPfizer; Cancer Research Malaysia; Pantai Hospital Kuala Lumpur; Hospital Sultan...RecruitingTriple Negative Breast Cancer | HRD 100 Gene Expression HighMalaysia
-
BeiGeneTerminatedMetastatic Castration-Resistant Prostate Cancer (mCRPC) | Homologous Recombination Deficiency (HRD)United States, Australia, Puerto Rico, Spain
-
German Breast GroupAstraZenecaCompletedBreast Cancer | Triple Negative Breast Neoplasms | HRpos Breast Neoplasms | BRCA 1 /2 and / or HRDGermany
-
University of MinnesotaNational Institutes of Health (NIH)CompletedSmoking Abstinence | HRT | Non-HRT | Continued Smoking
-
Memorial Sloan Kettering Cancer CenterMerck Sharp & Dohme LLCRecruitingMetastatic Pancreatic Ductal Adenocarcinoma | Homologous Recombination Deficiency (HRD)United States
-
Planexta, IncPharmaxi LLCCompleted
-
San Diego State UniversityCompletedGlucose Tolerance | HRVUnited States
-
Ying LinRecruitingHer-2 Negative Breast Cancer | HRR Gene MutationChina
-
M.D. Anderson Cancer CenterActive, not recruiting
-
Hadassah Medical OrganizationUnknown
-
Xianmin Song, MDRecruiting
-
Wageningen University and ResearchAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); FrieslandCampina...RecruitingHealthy With Hard and/or Lumpy StoolsNetherlands
-
National Cancer Institute (NCI)RecruitingAdvanced Solid Tumors | SCLC | HRD CancerUnited States
-
Damascus UniversityCompletedPatients Who Had Undergone Partial or Complete MaxillectomySyrian Arab Republic
-
GlycoMimetics IncorporatedTerminatedBreast Cancer | Breast Cancer Metastatic | HR+ Metastatic Breast CancerUnited States
-
Xiaoxiang ChenNot yet recruitingOvarian Cancer | HRD | Platinum-sensitive Ovarian CancerChina
-
Nordic MDS GroupUnknownMDS | SCT | MRDDenmark, Norway, Sweden
-
Case Comprehensive Cancer CenterSuspendedHR-positive Breast CancerUnited States
-
Olema Pharmaceuticals, Inc.NovartisRecruitingAdvanced Breast Cancer | Metastatic Breast Cancer | HR-positive Breast Cancer | HER2-negative Breast CancerUnited States, Australia
-
Galderma R&DCompleted
-
Novartis PharmaceuticalsRecruiting
-
Beijing 302 HospitalNot yet recruitingHR+/HER2- Advanced Breast CancerChina
-
Fudan UniversityNot yet recruiting
-
Hunan Cancer HospitalRecruiting
-
Jazz PharmaceuticalsActive, not recruitingHER2+/HR+ Breast CancerUnited States, Spain, Canada
-
Tehran University of Medical SciencesCompleted3rd Year Medical School's StudentsIran, Islamic Republic of
-
Ana C Garrido-Castro, MDMerck Sharp & Dohme LLC; Gilead SciencesActive, not recruitingMetastatic Breast Cancer | Invasive Breast Cancer | HER2-negative Breast Cancer | HR-Positive Breast CancerUnited States
-
Larissa University HospitalCompletedShoulder Surgery | Autonomic Nervous System | Interscalene Block | HRV | Beach Chair PositionGreece
-
Fudan UniversityNot yet recruitingNeoadjuvant Therapy | Early Breast Cancer | HR+HER2- Breast Cancer
-
Kafkas UniversityCompletedHealthy Mothers Who Have Had Both Vaginal and Cesarean DeliveriesTurkey
-
Novartis PharmaceuticalsNo longer availableHR+ Advanced or Metastatic Breast Cancer
-
Novartis PharmaceuticalsAvailableHR+, HER2-, Advanced Breast Cancer
-
Xiaoxiang ChenNot yet recruitingOvarian Cancer | HRD | PARP InhibitorChina
-
Ataturk UniversityCompleted3rd Level Intensive Care UnitTurkey
-
Nanjing Chia-tai Tianqing PharmaceuticalRecruitingHR Positive/HER-2 Negative Breast CancerChina
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.RecruitingHR-positive, HER2-negative Advanced Breast CancerChina
-
Novartis PharmaceuticalsNo longer availableAdvanced Hormone Receptor Positive (HR+) Breast Cancer
-
Henan Cancer HospitalRecruitingHR Positive HER2 Negative Advanced Breast CancerChina
-
PfizerCompletedHR+/HER2- Locally Advanced, Metastatic Breast CancerUnited Kingdom
-
Northwestern UniversityCompletedThe Duration of Motor Block May Vary Between 12-36 HrsUnited States
-
Rambam Health Care CampusCompletedWomen Who Had at Lease One Cesarean Section in the Past
-
Aduro Biotech, Inc.Johns Hopkins UniversityCompleted2nd-line, 3rd-line and Greater Metastatic Pancreatic CancerUnited States, Canada
-
Sichuan Baili Pharmaceutical Co., Ltd.Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.Recruiting
-
Henan Cancer HospitalNot yet recruitingAdvanced Breast Cancer | Treatment | HR Low/HER2 Negative